These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 32697849

  • 1. Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
    Ricord M, Andrews FM, Yñiguez FJM, Keowen M, Garza F, Paul L, Chapman A, Banse HE.
    Equine Vet J; 2021 Mar; 53(2):356-363. PubMed ID: 32697849
    [Abstract] [Full Text] [Related]

  • 2. Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses.
    Li Z, Du S, Wang X, Zhang L, Liu X, Fan Q, Yang H, Gao R.
    Equine Vet J; 2024 May; 56(3):562-572. PubMed ID: 37337455
    [Abstract] [Full Text] [Related]

  • 3. Effect of omeprazole and sucralfate on gastrointestinal injury in a fasting/NSAID model.
    Bishop RC, Kemper AM, Wilkins PA, McCoy AM.
    Equine Vet J; 2021 Oct 31. PubMed ID: 34719063
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic effects of Glycyrrhiza glabra root extract on phenylbutazone-induced Equine Glandular Gastric Disease (EGGD).
    Ahmadnejad M, Jalilzadeh-Amin G, Sykes BW.
    J Equine Vet Sci; 2022 Nov 31; 118():104088. PubMed ID: 35908599
    [Abstract] [Full Text] [Related]

  • 5. Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome.
    Bush J, van den Boom R, Franklin S.
    Equine Vet J; 2018 Jan 31; 50(1):34-40. PubMed ID: 28555939
    [Abstract] [Full Text] [Related]

  • 6. Comparison of oral esomeprazole and oral omeprazole in the treatment of equine squamous gastric disease.
    Sundra T, Gough S, Rossi G, Kelty E, Rendle D.
    Equine Vet J; 2024 Sep 31; 56(5):952-958. PubMed ID: 37678812
    [Abstract] [Full Text] [Related]

  • 7. A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial.
    Busechian S, Conti MB, Sgorbini M, Conte G, Marchesi MC, Pieramati C, Zappulla F, Vitale V, Rueca F.
    J Equine Vet Sci; 2023 Jul 31; 126():104296. PubMed ID: 37003396
    [Abstract] [Full Text] [Related]

  • 8. Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone.
    Tesena P, Yingchutrakul Y, Roytrakul S, Wongtawan T, Angkanaporn K.
    J Vet Med Sci; 2019 Mar 20; 81(3):418-424. PubMed ID: 30674748
    [Abstract] [Full Text] [Related]

  • 9. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
    Reed SK, Messer NT, Tessman RK, Keegan KG.
    Am J Vet Res; 2006 Mar 20; 67(3):398-402. PubMed ID: 16506899
    [Abstract] [Full Text] [Related]

  • 10. Equine gastric ulcer syndrome in adult horses.
    van den Boom R.
    Vet J; 2022 Mar 20; 283-284():105830. PubMed ID: 35472513
    [Abstract] [Full Text] [Related]

  • 11. Five- versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease.
    Sundra T, Kelty E, Rendle D.
    Equine Vet J; 2024 Jan 20; 56(1):51-58. PubMed ID: 36977610
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses.
    Monreal L, Sabaté D, Segura D, Mayós I, Homedes J.
    Res Vet Sci; 2004 Apr 20; 76(2):145-9. PubMed ID: 14672858
    [Abstract] [Full Text] [Related]

  • 14. Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
    Andrews FM, Reinemeyer CR, Longhofer SL.
    Vet Ther; 2009 Apr 20; 10(3):113-20. PubMed ID: 20037965
    [Abstract] [Full Text] [Related]

  • 15. Gastric microbiome in horses with and without equine glandular gastric disease.
    Paul LJ, Ericsson AC, Andrews FM, Keowen ML, Morales Yniguez F, Garza F, Banse HE.
    J Vet Intern Med; 2021 Sep 20; 35(5):2458-2464. PubMed ID: 34351018
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a questionnaire to detect the risk of developing ESGD or EGGD in horses.
    Busechian S, Sgorbini M, Orvieto S, Pisello L, Zappulla F, Briganti A, Nocera I, Conte G, Rueca F.
    Prev Vet Med; 2021 Mar 20; 188():105285. PubMed ID: 33530014
    [Abstract] [Full Text] [Related]

  • 17. Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E2 concentrations.
    Pedersen SK, Cribb AE, Read EK, French D, Banse HE.
    J Vet Pharmacol Ther; 2018 Apr 20; 41(2):239-245. PubMed ID: 29148168
    [Abstract] [Full Text] [Related]

  • 18. Effects of phenylbutazone alone or in combination with a nutritional therapeutic on gastric ulcers, intestinal permeability, and fecal microbiota in horses.
    Whitfield-Cargile CM, Coleman MC, Cohen ND, Chamoun-Emanuelli AM, DeSolis CN, Tetrault T, Sowinski R, Bradbery A, Much M.
    J Vet Intern Med; 2021 Mar 20; 35(2):1121-1130. PubMed ID: 33656183
    [Abstract] [Full Text] [Related]

  • 19. Changes in saliva analytes in equine gastric ulcer syndrome (EGUS) after treatment: a pilot study.
    Muñoz-Prieto A, Llamas-Amor E, Cerón JJ, Hansen S.
    Res Vet Sci; 2024 Aug 20; 176():105346. PubMed ID: 38968646
    [Abstract] [Full Text] [Related]

  • 20. Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses.
    Richardson LM, Whitfield-Cargile CM, Cohen ND, Chamoun-Emanuelli AM, Dockery HJ.
    Vet Surg; 2018 Aug 20; 47(6):784-791. PubMed ID: 30094858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.